Net Loss of ANG Lifesciences India reported to Rs 2.01 crore in the quarter ended June 2025 as against net loss of Rs 3.07 crore during the previous quarter ended June 2024. Sales rose 33.62% to Rs 24.60 crore in the quarter ended June 2025 as against Rs 18.41 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended | ||
| Jun. 2025 | Jun. 2024 | % Var. | |
| Sales | 24.60 | 18.41 | 34 |
| OPM % | 2.60 | -9.23 | - |
| PBDT | -1.20 | -2.51 | 52 |
| PBT | -2.73 | -4.14 | 34 |
| NP | -2.01 | -3.07 | 35 |
Powered by Capital Market - Live News